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ABSTRACT The mahogany (mg) locus originally was iden-
tified as a recessive suppressor of agouti, a locus encoding a
skin peptide that modifies coat color by antagonizing the
melanocyte-stimulating hormone receptor or MC1-R. Certain
dominant alleles of agouti cause an obesity syndrome when
ectopic expression of the peptide aberrantly antagonizes the
MC4-R, a related melanocyte-stimulating hormone receptor
expressed in hypothalamic circuitry and involved in the
regulation of feeding behavior and metabolism. Recent work
has demonstrated that mg, when homozygous, blocks not only
the ability of agouti to induce a yellow coat color when
expressed in the skin of the lethal yellow mouse (AY), but also
the obesity resulting from ectopic expression of agouti in the
brain. Detailed analysis of mgymg AYya animals, presented
here, demonstrates that mgymg blocks the obesity, hyperin-
sulinemia, and increased linear growth induced by ectopic
expression of the agouti peptide. Remarkably, however,
mgymg did not reduce hyperphagia in the AYya mouse.
Furthermore, mgymg induced hyperphagia and an increase in
basal metabolic rate in the C57BLy6J mouse in the absence
of AY. Consequently, although mahogany is broadly required
for agouti peptide action, it also appears to be involved in the
control of metabolic rate and feeding behavior independent of
its suppression of agouti.
The 131-aa agouti peptide is synthesized in the follicular cells
of the dermal papilla and acts in a paracrine fashion on
melanocytes where it antagonizes the binding of a-melano-
cyte-stimulating hormone (MSH) to melanocortin-1 receptor
or MC1-R (1, 2). The transcription of the wild-type mouse
agouti is temporally and spatially regulated, the gene being
expressed solely in the skin during part of the hair-growth cycle
where it gives rise to a subapical yellow pigment band in the
growing hair shaft (3). Several dominant alleles at the mouse
agouti locus (e.g., lethal yellow, AY, and viable yellow, AVY),
however, have an ectopic pattern of expression caused by
promoter gene rearrangement (4), and are associated pheno-
typically with yellow fur, late-onset obesity, hyperphagia, in-
creased linear growth, and noninsulin-dependent diabetes (3,
4). Recent studies have provided an explanation for the
development of the lethal yellow obesity syndrome. In vitro
experiments using recombinant agouti protein in a human
embryonic kidney 293 cell system have identified the peptide
not only as a MC1-R antagonist but also as a high affinity,
competitive antagonist of a melanocortin receptor subtype,
MC4 (1), widely expressed in regions of the hypothalamus
known to be involved in the regulation of feeding behavior and
metabolism (5, 6). Genetic and pharmacological studies have
concluded that disruption of MC4-R signaling is the primary
cause of the AY-induced obesity syndrome (7, 8). The MC4-R
knockout (MC4-R KO) mouse recapitulates all phenotypic
aspects of the agouti obesity syndrome (8). Moreover, intra-
cerebroventricular administration of a melanocortin analogue,
MTII, a potent agonist of the MC3 and MC4 receptors,
suppresses feeding behavior in rodents, whereas injection of
SHU9119, an antagonist of the same receptors, has the op-
posite effect (7). The pharmacological and genetic evidence
point out two major conclusions: first, neurons expressing
MC4-R exert a tonic inhibition on feeding behavior, and
second, development of the agouti obesity syndrome is caused
by chronic antagonism of MC4-R signaling by agouti. The
recent discovery in the hypothalamus of another antagonist of
MC3 and MC4 receptors, the agouti-related protein (Agrp)
(9), or agouti-related transcript (ART) (10), raises the intrigu-
ing possibility that ectopic expression of agouti mimics the
function of endogenous Agrp in the central control of energy
homeostasis. Overexpression of Agrp in the mouse animal
model results in an obesity and diabetes phenotype very much
like that seen in the AY and MC4-R KO mice (9, 11), further
demonstrating that MC4-R, activated by a-MSH or a-MSH
analogues and endogenously antagonized by Agrp, is an
important modulator of metabolic state. Future studies will be
required to determine whether the MC3-R also is involved in
the control of energy homeostasis.
The murine mahogany (mg) and mahoganoid (md) loci were
identified in the sixties as recessive suppressors of AY-induced
pigmentation, which were able to shift melanogenesis from the
phaeomelanin (redyyellow pigment) pathway toward eumela-
nin (blackybrown pigment) production (12, 13). Early genetic
studies positioned mg and md on chromosomes 2 and 16,
respectively (14); however, several decades later the mg and md
gene products remain unidentified. The murine mahogany
locus is characterized by two mutations, mg, which originated
in the LDJyLe background, and mg3J in the C3HeByFeJ
background (15). The md coat color mutation originated in the
C3HyHeJ genetic background (15). Recently, mg and md were
found to suppress not only the yellow coat color but also the
AY-induced increase in body weight (15), suggesting that they
are required for agouti action both in the skin as well as in the
brain. These studies also indicate that md and mg are partially
semidominant, because both genes show some ability to sup-
press phaeomelanin synthesis as well as obesity in the AY
mouse (md only) when heterozygous (15). Two possible mech-
anisms proposed for mg action by the recent studies include
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interference with agouti peptide processing or secretion, or
disruption of its interaction with melanocortin receptors (15).
Although mg has been demonstrated to decrease weight gain
in the AYy2 mouse, no detailed analysis of the physiological
effects of mg in the presence or absence of the AY gene has
been published. Analysis of weight, body composition, linear
growth, serum insulin, leptin, glucose, and corticosterone,
feeding behavior, circadian rhythms, and basal metabolic rate
(BMR) in mgymg AYya and normal mgymg aya mice is
presented here. Data on the effect of mdymd on feeding
behavior also is presented.
MATERIALS AND METHODS
Mice. To study the action of mg, AY, and ob genes in a
uniform genetic background we recovered the mg mutation
from the LDJyLe background. All of our studies were per-
formed on mice homozygous for the mg mutation backcrossed
by one of us (M.L.L.) for 6–8 generations to the C57BLy6J
background. The AY and ob alleles also were derived from
congenic C57BLy6J mice (Jackson Laboratories, Bar Harbor,
ME). Animals homozygous for the md mutation and their
controls originated in the C3HyHeJ background (Jackson
Laboratories). Mice were housed as siblings, maintained at 23°
6 1°C on a 12-hy12-h lightydark cycle (7:00–19:00 h), and
allowed free access to water and food (Purina, St. Louis, MO).
All studies were conducted under guidelines provided by the
Animal Care and Use Committee of Oregon Health Sciences
University.
Body and Organ Weight. To study the effect of mgymg on
AY-induced weight gain, C57BLy6J mice of four different
genotypes (1y1 aya, 1y1 AYya, mgymg aya, and mgymg
AYya), were regularly weighed as littermates. For organ weight
measurements different white fat pads (epididymal, visceral,
and dorsal), brown fat, heart, and liver were dissected and
weighed. Weight growth curves also were determined for 1y1
aya, 1y1 obyob, mgymg aya, and mgymg obyob mice.
Body Length Measurements. Animals were lightly anesthe-
tized with 2% avertin and extended to their maximal length to
determine the nose-to-anus distance, a measure of their linear
growth.
Food Intake. For measurement of food consumption, ani-
mals of four genotypes (1y1 aya, 1y1 AYya, mgymg aya,
and mgymg AYya) were housed individually for at least 2
weeks before beginning the experiment. Preweighed standard
chow pellets (4.5% fat) were provided to mice ad libitum in
Petri dishes, and measurements of the remaining food were
taken every 24 h for a 7-day period. To minimize food spillage
mice were housed in cages with no bedding, and they were
given only 2–3 food pellets at one time. The effect of mdymd
on food intake was analyzed by measuring weekly food con-
sumption (9% fat diet) for mdymd AyA and 1y1 AyA
controls. Data from both experiments are presented as
gymouse per day for comparative purposes.
Blood Analysis. Animals were sacrificed by cervical dislo-
cation between 16:00 and 18:00 h, and trunk blood was
collected. Serum insulin and leptin concentrations were de-
termined in duplicate by using radioimmunoassay kits with rat
insulin and recombinant leptin, respectively, as standards
(Linco Research Immunoassay, St. Charles, MO). For serum
corticosterone measurements, blood was collected from the
tail vein within 1 min of handling, and corticosterone levels
were measured in the serum by using a radioimmunoassay kit
(ICN). Blood glucose concentrations were measured by using
a One-Touch Profile glucose meter (Lifescan, Milpitas, CA).
Motor Activity. Animals were housed individually in meta-
bolic cages equipped with a running wheel (Mini-Mitter,
Sunriver, OR). The metabolic cages allowed telemetric mon-
itoring of circadian rhythms as assessed via two physiological
parameters: temperature and number of wheel turns. The
wheel revolutions were quantified by recording the magnetic
switch closures of a magnet placed on the revolving wheel. For
temperature recordings mice were implanted with a radio-
transmitter in the peritoneal cavity and allowed to recover for
1 week. Temperature was monitored by sampling series of
digital pulses from the implanted transmitter.
BMR. Oxygen consumption was simultaneously determined
for multiple animals by indirect calorimetry using an Oxymax
System (Columbus Instruments, Columbus, OH). For this
purpose animals were housed in separate chambers main-
tained at 24° 6 1°C. Before beginning the experiment animals
were acclimatized to the chambers and then measurements
were taken for 4–5 h during the middle of the light cycle
(11:00–16:00 h). Samples were recorded every 3 min with the
room air reference taken every 30 min and the air f low to
chambers 500 mlymin. Basal oxygen consumption was deter-
mined for individual curves as the average at the lowest plateau
regions that corresponded to resting periods. Total oxygen
consumption was the result of all samples recorded corre-
sponding to periods of movement as well as inactivity.
Statistical Analysis. All data are presented as mean 6 SEM.
Growth curves were analyzed by ANOVA with multiple
measurements. All other statistical comparisons between dif-
ferent strains were performed by Student’s two-tailed t test
with P , 0.05 considered significant.
RESULTS
mg Suppresses AY-Induced Obesity. The main focus of our
physiological characterization was to compare and contrast the
phenotypes of mgymg AYya and 1y1 AYya mice, the first step
being to determine which of the AY-mediated obesity param-
eters were suppressed by mg. We determined growth curves for
1y1 AYya, mgymg AYya, mgymg aya, and 1y1 aya female
mice housed as siblings and maintained on a low-fat rodent
chow (Fig. 1A). The weight gain of the animals was monitored
regularly between 4 and 24 weeks of age. All weight curves,
with the exception of mgymg aya versus 1y1 aya wild-type
controls, were significantly different as analyzed by ANOVA
with multiple measurements (P , 0.0001). As previously
reported (16, 17), 1y1 AYya mice are characterized by a
progressive increase in their body weight starting at approxi-
mately 2 months for female mice as compared with wild-type
controls. By 6 months of age there is an approximate 24%
increase in 1y1 AYya body weight versus mgymg AYya (P
, 0.01), which indicates that mg is able to suppress the
AY-induced weight gain. Similar data on the suppression of
AY-induced weight increase by mgymg were found in
LDJyLeyC57BLy6J hybrids and in non-littermates in the
C57BLy6J background (15). In contrast, homozygosity of mg
was not found to suppress the weight gain in the obyob mouse
during the 20-week period studied (Fig. 1B). The apparent
decrease in body weight of mgymg obyob versus 1y1 obyob
seen at 16 weeks of age was caused by incomplete sampling of
weights during this time period (n 5 1–3), and was not
significant, as can be seen by examination of the mean weights
at 19 or 20 weeks (n 5 6). To investigate whether the
AY-induced gain in body weight is caused by an increase in body
fat mass, various fat pads, heart, and liver from 23-week-old
animals were dissected and measured. The results presented in
Table 1 further show the absence of obesity in mgymg AYya
mice. The weights of the different tissues we examined, with
the exception of heart, were significantly decreased in mgymg
AYya mice, presumably because of less triglyceride accumu-
lation, and were equivalent to those found in wild-type controls
(data not shown).
mg Suppresses AY-Induced Increased Linear Growth. Body
length (nose-to-anus distance) was determined for 23-week-
old 1y1 AYya, mgymg AYya, and mgymg aya males, respec-
tively. Our results indicate that 1y1 AYya are approximately
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6.1% (P , 0.001) longer than mgymg AYya animals and 5.9%
(P , 0.001) longer than mgymg aya age-matched controls
(Fig. 2).
mg Blocks the Endocrine Effects of AY-Induced Obesity:
Serum Insulin, Leptin, Glucose, and Corticosterone Measure-
ments. Blood was collected from 22-week-old 1y1 AYya,
mgymg AYya, mgymg aya, and 1y1 aya male animals and
assayed for insulin and leptin concentrations. Our analysis
indicates that 1y1 AYya mice exhibit elevated insulin (Fig.
3A) and leptin (Fig. 3B) levels, a 5.6-fold (P , 0.01) and a
2.5-fold (P , 0.01) increase, respectively, over their mgymg
AYya, or 1y1 aya counterparts. No significant differences
were detected among the other groups. The high serum leptin
and insulin concentrations found in 1y1 AYya animals are
correlated with their progressive increase in body fat and lipid
deposition. The AY–induced hyperglycemia also was found to
be suppressed by mg as 26-week-old mgymg AYya male
animals (n 5 6) had blood glucose concentrations (114 6 2.0
mgydl) significantly lower (P 5 0.0001) than 1y1 AYya
(131 6 3.0 mgydl, n 5 7). No differences in basal corticoste-
rone levels were found between genotypes (3-month-old
males, n 5 5, data not shown).
mgymg AYya Mice Remain Hyperphagic, and Both mg and
md Independently Induce Hyperphagia. The progressive
weight gain and increase in adipose tissue that characterize
1y1 AYya animals result from both increased caloric intake
and decreased energy expenditure. We decided therefore to
look at both aspects of energy balance. The food consumption
of 28-week-old females, representing the four genotypes:
mgymg AYya, mgymg aya, 1y1 AYya, and 1y1 aya, was
monitored over a 7-day period. In agreement with previous
reports (8, 16), 1y1 AYya mice are hyperphagic, their average
daily food intake in this assay being significantly higher (5.9 6
0.1 gy24 h, P , 0.0001) than C57BLy6J controls (4.6 6 0.2
gy24 h). Surprisingly, mgymg did not appear to reduce AY-
induced hyperphagia as we found no significant difference
between 1y1 AYya and mgymg AYya caloric intake (Fig. 4A),
despite a 24% difference in their body weight. Furthermore,
mgymg alone induced hyperphagia, the presence of homozy-
gous mg in the absence of AY resulting in an approximate 22%
increase in food intake (5.7 6 0.2 gy24 h versus 4.6 6 0.2 gy24
h, P , 0.0001) over C57BLy6J controls of equal weight. As it
has previously been shown that the md locus encodes a
phenocopy of mg (12, 15), we examined the effect of mdymd
on food intake as well. Homozygosity for md also resulted in
hyperphagia (Fig. 4B).
mg Increases Motor Activity and BMR. In light of the finding
that mgymg mice were hyperphagic, it became essential to
determine how these animals remained lean while consuming
22% more calories. Therefore, the two major components of
daily energy expenditure, BMR and energy expenditure
FIG. 1. (A) mg suppresses AY-induced weight gain. Data are
collected from female animals (n 5 4–5 for each genotype). (B) mg
has no effect on ob-induced weight gain. Weight growth curves were
determined for female mgymg obyob (n 5 6), mgymg aya (n 5 8),
1y1 obyob (n 5 3), and 1y1 aya control mice (n 5 8). All data are
presented as mean 6 SEM.
FIG. 2. mg suppresses AY-induced increased linear growth. Body
length (naso-anal) measurements were taken from 24- to 28-week-old
male 1y1 AYya (n 5 4), mgymg AYya (n 5 3), and mgymg aya animals
(n 5 3). Data are presented as mean 6 SEM. ppp, P , 0.001.
Table 1. Body and organ weight measurements
Genotype Body weight VF EPI DF BAT L H
1/1 AY/a 35.26 6 1.72 0.87 6 0.15 1.49 6 0.14 0.85 6 0.09 0.16 6 0.02 1.55 6 0.1 0.18 6 0.01
mg/mg AY/a 26.99 6 0.87 0.33 6 0.06 0.27 6 0.03 0.57 6 0.05 0.08 6 0.01 1.16 6 0.1 0.23 6 0.02
P value P , 0.05 P , 0.05 P , 0.001 P , 0.05 P , 0.05 P , 0.05 P . 0.05
mg suppresses AY-induced increase in adiposity. White fat pads: epididymal (EPI), visceral 5 mesenteric 1 retroperitoneal (VF), dorsal (DF),
brown fat (BAT), heart (H), and liver (L) from 23-week-old male 1/1 AY/a (n 5 6) and mg/mg AY/a animals (n 5 3) were dissected and weighed.
All data are reported as mean 6 SEM.
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caused by physical activity, were determined as a function of
genotype. Activity on an exercise wheel was measured in
mgymg AYya and 1y1 AYya, as well as in mgymg aya versus
1y1 aya mice. mgymg AYya animals showed increased
nighttime activity, and a corresponding 0.5°C gain in body
temperature correlating with the increased exercise (Fig. 5 A
and B, representative 48-h traces). During nighttime mgymg
AYya exhibited an approximate 2-fold increase (P , 0.0001) in
the number of wheel turns over 1y1 AYya animals (Fig. 5C),
whereas mgymg aya showed a 30% increase in their motor
activity (P , 0.0001) when compared with wild-type mice (Fig.
5D). We concluded that presence of the mg gene was sufficient
to augment physical activity and therefore caloric usage during
nighttime. We further analyzed BMR in 20- to 28-week-old
animals. At the time of our experiment 1y1 AYya mice were
significantly heavier than their age-matched mgymg AYya
complements (39.7 6 2.3 g versus 29.1 6 1.6 g, P , 0.01). On
a per-animal basis, no significant difference in oxygen con-
sumption could be detected when comparing the 1y1 AYya
and mgymg AYya mice (Fig. 5E). Surprisingly, mgymg aya
animals (27.4 6 0.9 g) showed an approximate 21% gain (P ,
0.0001) in their BMR over weight-matched wild-type controls
(26.2 6 0.4 g, Fig. 5F). Our results indicate therefore that
mgymg significantly elevates BMR in the normal C57BLy6J
animal.
DISCUSSION
Data presented here demonstrate that, with one very impor-
tant exception (hyperphagia), homozygous mg suppresses the
phenotypes of the lethal yellow obesity syndrome: adult-onset
obesity, hyperinsulinemia, hyperleptinemia, hyperglycemia,
and increased linear growth. The results show that mgymg
AYya mice have a normal body size and adiposity, and their
insulin and leptin levels are comparable to wild-type values.
The ability of mgymg to suppress the centrally mediated effects
of agouti on feeding and endocrine parameters, as well as the
peripherally mediated inhibition of eumelanin synthesis by
agouti in the melanocyte, suggests that the mg gene product is
expressed and functions in both brain and skin. In the AY
mouse, in which the skin agouti peptide is ubiquitously ex-
pressed, mg is clearly required for agouti function in the
hypothalamus. In the C57BLy6J animal, a potential target for
mg action in the brain, where agouti is not normally expressed,
could be the recently discovered hypothalamic Agrp. Further-
more, it is noteworthy that according to results presented here
the effects of mg and md gene products are not limited to
agouti andyor Agrp, because inhibition of the function of
either of these peptides would not be expected to lead to
hyperphagia, but precisely the opposite. Thus, the ability of
FIG. 3. mg suppresses the endocrine effects of the agouti obesity
syndrome: hyperinsulinemia and hyperleptinemia. (A) Serum insulin.
(B) Serum leptin. Males (22 weeks old, n 5 5 for each genotype) were
used for serum insulin and leptin measurements. All data are pre-
sented as mean 6 SEM. pp, P , 0.01.
FIG. 4. mg and md independently induce hyperphagia. (A) Food
intake was measured daily over a 7-day period for 28-week-old females
(n 5 4–5 for each group). Data are reported as mean of seven
measurements 6 SEM. (B) Food consumption of mdymd AyA males
and 1y1 AyA controls (n 5 4 for each genotype) was monitored
weekly between 6 and 16 weeks of age. Data are presented as average
of 11 measurements 6 SEM. ppp, P # 0.0001.
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FIG. 5. mg increases motor activity and basal metabolic rate. (A) Circadian rhythm of wheel activity. (B) Circadian rhythm of body temperature.
Measurements were taken every 1 min during a 48-h time period for 24- to 28-week-old mgymg AYya and 1y1 AYya animals (representative traces
from 48 h of recording, two miceygenotype). The regions of increased activity or temperature correspond to nighttime whereas no or low activity is seen
during daytime. (C and D) Quantitative comparison of average physical activity (wheel turns) as measured during nighttime in 20- to 28-week-old mgymg
AYya (n 5 7) and 1y1 AYya animals (n 5 9) (C) and in 26- to 34-week-old mgymg aya (n 5 5) versus 1y1 aya wild-type animals (n 5 5) (D). (E)
Oxygen consumption of 20- to 28-week-old mgymg AYya and 1y1 AYya mice (n 5 8 for each group) as measured by indirect calorimetry. (F) Oxygen
consumption of 20- to 28-week-old mgymg aya versus 1y1 aya wild-type animals as determined by indirect calorimetry (n 5 11 for each genotype).
Both male and female animals were included in all measurements. Data in C–F are reported as mean 6 SEM. ppp, P , 0.0001.
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homozygous mg to induce hyperphagia implies pathways of
action of the mg gene that are independent of agouti and Agrp.
Because hyperphagia in the mgymg AYya mice could be mg or
AY-driven, it cannot be determined from the data presented
here whether mg actually suppresses AY-induced hyperphagia
and concurrently induces hyperphagia via a different pathway.
Interestingly, the inability of mgymg to suppress obesity in the
obyob mouse indicates that the effectors dependent on mg do
not include all peptide regulators of energy homeostasis,
because if this gene was required for neuropeptide Y action
(18) it might be expected to ameliorate the obesity resulting
from leptin deficiency.
The analysis of the mg phenotype demonstrates that ho-
mozygous mg increases BMR as well as physical activity in the
C57BLy6J animal. In the AYya mouse mgymg also elevates
physical activity; however, an increase in BMR is not detected
on a per-animal basis. BMR is the major component of daily
energy expenditure, accounting for up to 70% of the caloric
utilization. The factors that regulate BMR include hormonal
stimuli (i.e., thyroid hormone) and the sympathetic nervous
system. These modulators remain to be investigated in the mg
animal. The phenotype of hyperphagia present in the mgymg
mouse potentially could be secondary to elevation of its
metabolic rate in an attempt to overcome a negative energy
balance and maintain body weight homeostasis. This sugges-
tion is supported by the preliminary observation that mg
animals lose significantly more body weight than their coun-
terparts after a 24-h fast (mgymg aya: 4.62 6 0.29 g versus
1y1 aya: 3.38 6 0.18 g, P , 0.01, n 5 4–5). It is interesting
that mice homozygous for the md mutation in the C3HyHeJ
background display the same hyperphagia phenotype seen by
us in C57BLy6J-mgymg animals, demonstrating that both
agouti suppressors can alter feeding behavior independent of
background strain.
Based on the analysis of energy intake and expenditure in
mgymg animals we conclude that the pathways in which mg
functions are largely overlapping with proopiomelanocortin-
agouti-Agrp melanocortinergic neurocircuits, but also appear
to include independent pathways regulating metabolic rate and
feeding behavior.
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